Cytology and DNA HPV-testing in the era of HPV-vaccine
Rola cytologii i testu DNA HPV w erze szczepionki antywirusowej release_vufwnlr4vrhurj5js64cm37atq

by Marek Spaczyński, Blanka Malkowska-Walczak, Ewa Nowak-Markwitz

Published in Ginekologia Polska .

2007   Volume 78, Issue 9, p696-700

Abstract

Human papillomavirus (HPV) persistent infection is the main factor leading to the cervical cancer carcinogenesis. Wide-spread public vaccination against HPV as primary prevention is expected to reduce cervical cancer incidence and mortality rates. It is essential to bear in mind that screening for precancerous lesions cannot be discontinued because vaccination will not protect the patients against HPV types which have not been included in the first and second generation of vaccines.
In text/plain format

Archived Files and Locations

application/pdf   248.6 kB
file_p567bhiwara7tk25iawjfvrljm
journals.viamedica.pl (web)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Year   2007
Language   pl ?
PubMed  18159823
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
Not in Keepers Registry
ISSN-L:  0017-0011
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: f8c544d8-a06e-4647-a95f-321719ed3d78
API URL: JSON